Treatment Outcomes of Multidrug‑Resistant Tuberculosis Patients in East Java, Indonesia: A Retrospective Cohort Analysis
Background: The drug regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) has lower potency, is more costly, and has a greater risk of adverse effects than first‑line anti‑TB drugs. We aimed to compare the treatment outcomes of patients using standard shorter regimen (STR regimen...
محفوظ في:
المؤلفون الرئيسيون: | Indarti, Hardini Tri, Kristin, Erna, Soedarsono, Soedarsono, Endarti, Dwi |
---|---|
التنسيق: | مقال PeerReviewed |
اللغة: | English |
منشور في: |
Wolters Kluwer
2022
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://repository.ugm.ac.id/283429/1/220.pdf https://repository.ugm.ac.id/283429/ https://journals.lww.com/ijmy/fulltext/2022/11030/treatment_outcomes_of_multidrug_resistant.6.aspx |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Comparison of Chest X-Ray Findings Between Primary and Secondary Multidrug Resistant Pulmonary Tuberculosis
بواسطة: Ricky Septafianty, Ricky, وآخرون -
Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: A retrospective study
بواسطة: Ye Minn Htun, وآخرون
منشور في: (2019) -
The Battle Continues: An Interpretative Phenomenological Analysis of the Experiences of Multidrug-Resistant Tuberculosis (MDR-TB) Patients
بواسطة: Teh, Lota A, وآخرون
منشور في: (2018) -
Quinolones and multidrug-resistant tuberculosis
بواسطة: Khun Nanta Maranetra
منشور في: (2018) -
A Woman with Tuberculosis Multidrug Resistance and QTc Prolongation Repetitive Interval: A Case Report
بواسطة: Tutik Kusmiati, Tutik, وآخرون